Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X
Whitepaper

Micromeritics’ Solutions Identify and Control Critical Quality Attributes

Quality by design (QbD) is a developmental approach, which predefines objectives and emphasises understanding of product s and process control from science and quality risk management.

Achieving QbD requires an in depth understanding of psychochemical properties, which predict processability, in vivo, and in vitrio performance. Early identification of critical quality attributes (CQA) of excipients and active pharmaceutical ingredients (API) and their impact on a formulation is a key component of QbD.

Micromeritics’ Instruments and contract analytical services offers solutions for the early identification of CQAs, continuous process monitoring, and verification, which are the foundations of QbD.

Download to find out more.

Micromeritics’ Solutions Identify and Control Critical Quality Attributes

For Free, instant access, click below.

Download Whitepaper

I have read and accept the terms and conditions and privacy policy.
We'd like to keep you informed about relevant promotions, products and services, if you would like not to receive these, check this box.
If you would like to hear from carefully selected third party companies, check this box
Follow this company to receive notifications when they update.




Thank You

Your white paper is now downloading... Click here if the download does not begin.

Go Top